Bacteria and antimicrobial agents in the treatment of acne

International Journal of Dermatology

Volumn 35, Issue 4, 1996, Pages 249-251

  Parry, Eileen J ^a   Griffiths, Christopher E M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; DOXYCYCLINE; PENICILLIN DERIVATIVE;

ACNE; HUMAN; ORAL DRUG ADMINISTRATION; PROPIONIBACTERIUM ACNES; SHORT SURVEY; TOPICAL DRUG ADMINISTRATION;

EID: 0029924482     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1996.tb02996.x     Document Type: Short Survey

References (15)

1. Gilchrist TC. The etiology of acne vulgaris. J Cutan Dis Syphilol 1903; 21:107-120.
2. Leyden JJ, McGinley KJ, Mills OH, Kligman AM. Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 1975; 65:382-384.
3. Leeming JP, Holland KT, Cunliffe WJ. The pathological and ecological significance of microorganisms colonising acne vulgaris comedones. J Med Microbiol 1985; 20:11-16.
4. Lavker RM, Leyden JJ, McGinley KJ. The relationship between bacteria and the abnormal follicular kera-tinization in acne vulgaris. J Invest Dermatol 1981: 77: 325-330.
5. Saint-Leger D, Bague A, Lefebvre E, et al. A possible role for squalene in the pathogenesis of acne. II. In vivo study of squalene oxides in skin surface and intracome-donal lipids of acne patients. Br J Dermatol 1986; 114: 543-552.
6. Holland KT, Cunliffe WJ, Roberts CD. The role of bacteria in acne vulgaris; a new approach. Clin Exp Dermatol 1978; 3:253-257.
7. Norris JFB, Cunliffe WJ. A histological and immunocytochemical study of early acne lesions. Br J Dermatol 1988; 118:651-659.
8. Webster GF, Leyden JJ. Characterization of serum-in-dependent polymorphonuclear leukocyte chemotactic factors produced by Proptonibacterium acnes. Inflammation 1980; 4:261-269.
9. Ad Hoc committee on the use of antibiotics in dermatology. Systemic antibiotics for treatment of acne vulgaris; efficacy and safety. Arch Dermatol 1975; 111: 1630-1636.
10. Stoughton RB. Topical antibiotics for acne vulgaris. Arch Dermatol 1979; 115:486-489.
11. Leyden JJ. Antibiotic-resistant acne. Cutis 1976; 17: 593-596.
12. Eady EA, Jones CE, Tipper JL, et al. Antibiotic-resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ 1993; 306:555-556.
13. Eady EA, Cove JH, Holland KT, Cunliffe WJ. Erythromycin-resistant propionibacteria in antibiotic-treated acne patients: association with therapeutic failure. Br J Dermatol 1989; 121:51-57.
14. Noble WC. Choice of topical antibiotic - a microbiological viewpoint. Clin Exp Dermatol 1981; 6:503-507.
15. Shalita AR, Smith JG, Parish LC, et al. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int J Dermatol 1995; 34:434-437.